Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Minoxidil in breast milk may harm nursing infants.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Tailor treatments for vitiligo to patient needs for best results.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.